Thus, ETAR blockade in CKD (in the setting of RAS inhibition) helps restore renal blood flow; this effect is likely mediated by afferent, and relatively greater efferent, arteriolar relaxation. This evidence concerns the gene EDNRA and chronic kidney disease.